Product Images Apidra Solostar
View Photos of Packaging, Labels & Appearance
Product Label Images
The following 27 images provide visual information about the product associated with Apidra Solostar NDC 0088-2502 by Sanofi-aventis U.s. Llc, such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.
This text appears to be a chart related to glucose levels measured in mg/dL along with the time in hours. It also mentions APDRA and REGULAR, but it's not clear what they refer to.*
The text provides glucose levels in mg/dL and mentions the terms aPDRA, post and REGULAR, pre. It also contains a graph with time in hours on the x-axis and glucose levels on the y-axis. However, the text is not sufficient to provide a complete description.*
This is a table that shows the insulin types "GLusine" and "Regular" with corresponding time intervals of 20 to 40 minutes. The text also mentions "INSULIN" at the top.*
This appears to be a physical description and diagram of a pen for injecting insulin. The diagram includes a protective seal, insulin reservoir with a window, outer and inner needle cap, dosage selector button, and rubber seal. The pen also indicates that it is designed to be used with pen needles, but these are not included in the package.*
This is a medication called Apidra® which contains insulin glulisine for injection. Each mL has 100 IU of insulin glulisine, along with other ingredients. The package insert contains information about dosage and administration. The medication should be used cautiously and only under medical supervision. An unopened Apidra® vial should be stored refrigerated and discarded after 28 days if left at room temperature. The opened vials can be kept unrefrigerated for up to 28 days. The manufacturer is sanofi-aventis U.S. LLC. The text also includes a warning to keep the medication out of reach of children, and a GTIN number.*
This is a description of a medical product by Sanofi for insulin glulisine injection in a disposable insulin delivery device. The product comes in a sealed carton containing five 3 mL prefilled pens and is for subcutaneous injection only. It is important to use the solution only if it is clear and colorless with no visible particles, and to use within 28 days after initial use. The product does not include needles.*
* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.